文献速递神经介入儿科影像DSA

视网膜母细胞瘤选择性眼动脉化学手术中辐射剂量的决定因素

Determinants of Radiation Dose in Selective Ophthalmic Artery Chemosurgery for Retinoblastoma.
PubMed 文献 · AJNR Am J Neuroradiol · 2019-03-14

回顾性分析英国国家视网膜母细胞瘤服务中心48例患儿共177次选择性眼动脉化学手术,平均透视时间13.5±13分钟、剂量面积积11.7±9.7 Gy.cm²、总皮肤剂量260.9±211.6 mGy;微导管尖端位于眼动脉近端或开口处及年龄≤2岁与透视时间和辐射剂量降低相关,超过第一个治疗周期与透视时间降低相关。

要点

  • 微导管尖端位于眼动脉近端或开口处、患儿年龄≤2岁与透视时间和辐射剂量降低相关。
  • 超过第一个治疗周期的操作与透视时间降低相关。
  • 177次手术中163次(92.1%)技术成功,14次(7.9%)初次失败,其中13次再尝试成功。

核心结论

  • 在选择性眼动脉化学手术中,微导管尖端位于眼动脉近端或开口处及患者年龄2岁或以下与透视时间和辐射剂量降低相关;超过第一个治疗周期的治疗与透视时间降低相关。

研究设计与样本

  • 单中心回顾性研究,纳入2013年至2017年英国国家视网膜母细胞瘤服务中心48例视网膜母细胞瘤患儿的177次选择性眼动脉化学手术,复习病历、血管造影图像和辐射剂量学数据(包括总透视筛查时间、皮肤剂量和剂量面积积)。

诊断标准与关键数值

  • 平均透视时间为13.5±13分钟。
  • 平均剂量面积积为11.7±9.7 Gy.cm²。
  • 平均总皮肤剂量为260.9±211.6 mGy。
  • 177次手术中163次(92.1%)技术成功;14次(7.9%)初次尝试失败,其中13次再尝试成功。

临床应用与阅片要点

  • 微导管尖端位于眼动脉近端或开口处与透视时间和辐射剂量降低相关。
  • 患者年龄2岁或以下与透视时间和辐射剂量降低相关。
  • 超过第一个治疗周期的治疗与透视时间降低相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Retinoblastoma is the most common pediatric ocular neoplasm. Multimodality treatment approaches are commonplace, and selective ophthalmic artery chemosurgery has emerged as a safe and effective treatment in selected patients. Minimizing radiation dose in this highly radiosensitive patient cohort is critical. We explore which procedural factors affect the radiation dose in a single-center cohort of children managed in the UK National Retinoblastoma Service.

MATERIALS AND METHODS: A retrospective review was performed of 177 selective ophthalmic artery chemosurgery procedures in 48 patients with retinoblastoma (2013-2017). Medical records, angiographic imaging, and radiation dosimetry data (including total fluoroscopic screening time, skin dose, and dose-area product) were reviewed.

RESULTS: The mean fluoroscopic time was 13.5 ± 13 minutes, the mean dose-area product was 11.7 ± 9.7 Gy.cm2, and the mean total skin dose was 260.9 ± 211.6 mGy. One hundred sixty-three of 177 procedures (92.1%) were technically successful. In 14 (7.9%), the initial attempt was unsuccessful (successful in 13/14 re-attempts). Screening time and radiation dose were associated with drug-delivery microcatheter location and patient age; screening time was associated with treatment cycle.

CONCLUSIONS: In selective ophthalmic artery chemosurgery, a microcatheter tip position in the proximal or ostial ophthalmic artery and patient age 2 years or younger were associated with reduced fluoroscopic screening time and radiation dose; treatment beyond the first cycle was associated with reduced fluoroscopic screening time.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Qureshi AM, Davies LK, Patel PA, et al. Determinants of Radiation Dose in Selective Ophthalmic Artery Chemosurgery for Retinoblastoma. AJNR Am J Neuroradiol. 2019. PMID: 30872423. doi:10.3174/ajnr.A6000

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。